Cargando…
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer
Metastatic colorectal cancer (mCRC) is characterized by the expression of cellular oncogenes, the loss of tumor suppressor gene function. Therefore, identifying integrated signaling between onco-suppressor genes may facilitate the development of effective therapy for mCRC. To investigate these pathw...
Autores principales: | Blanchard, Thomas G., Czinn, Steven J., Banerjee, Vivekjyoti, Sharda, Neha, Bafford, Andrea C., Mubariz, Fahad, Morozov, Dennis, Passaniti, Antonino, Ahmed, Hafiz, Banerjee, Aditi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406751/ https://www.ncbi.nlm.nih.gov/pubmed/30744076 http://dx.doi.org/10.3390/cancers11020199 |
Ejemplares similares
-
Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells
por: Banerjee, Aditi, et al.
Publicado: (2017) -
Impact of Andrographolide and Melatonin Combinatorial Drug Therapy on
Metastatic Colon Cancer Cells and Organoids
por: Sharda, Neha, et al.
Publicado: (2021) -
Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment
por: Banerjee, Aditi, et al.
Publicado: (2016) -
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020) -
Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)